HB 1923 establishes new workplace safety requirements for meat packing and food processing facilities by mandating facility health and safety committees. It creates a dedicated workers' rights coordinator position within the Department of Labor and Industry to oversee compliance and address concerns. The bill also adds specific public health emergency protections for workers during outbreaks or crises, requiring employers to follow state health guidelines. These changes directly affect workers and employers in the meat and food processing industry across the state.
HB 1643 modifies Pennsylvania law to clarify how courts enforce foreign judgments. It prohibits courts from enforcing foreign judgments related to reproductive health care services, including pregnancy-related care, contraception, or abortion. The bill specifies that such judgments cannot be enforced against providers for services delivered in medical facilities. This change applies to all foreign judgments filed in Pennsylvania courts under the existing enforcement procedures. The law takes effect 60 days after enactment.
HB 1641 prohibits Pennsylvania medical liability insurers from taking adverse actions against healthcare providers who offer legal reproductive health services, including abortion care via telemedicine, to out-of-state patients. It specifically bans insurers from refusing coverage renewals, raising premiums, or reporting providers solely for providing such services that comply with Pennsylvania law. The law applies to providers prescribing medication to terminate pregnancies for out-of-state patients using telemedicine. This directly affects insurers and healthcare providers serving patients in states with stricter abortion laws, preventing insurance penalties for legal telemedicine care.
HB 1640 protects patient privacy for reproductive health care records in Pennsylvania. It requires healthcare providers (covered entities) to obtain written permission from patients before sharing records related to permitted reproductive services - such as pregnancy care, contraception, or abortion - except in limited circumstances like court orders, abuse investigations, or legal defense needs. The law explicitly preserves existing confidentiality protections under other state laws, including those for mental health and domestic violence services. It applies directly to patients seeking reproductive health care and the healthcare providers handling their records.
HB 670 would protect access to abortion clinics in Pennsylvania by creating a legal right for people to enter reproductive health services facilities and allowing lawsuits against individuals or entities that block access. It amends criminal and judicial statutes to define "blocking access" as a violation and imposes penalties for such actions. The bill directly affects patients seeking abortion care, clinic staff, and anyone attempting to obstruct facility access. Key provisions include enabling civil lawsuits for damages and establishing specific criminal penalties for interference with facility access.
HB 1881 updates Pennsylvania's Pharmacy Act to modernize requirements for pharmacy technicians and trainees, including new registration qualifications and supervision rules by licensed pharmacists. It adds specific protocols for pharmacies administering injectable medications, biologicals (like vaccines), and immunizations, while requiring detailed reports on vaccine administration. The bill also establishes new standards for clinical laboratory certificates and repeals outdated sections of the original 1961 law. These changes directly affect pharmacies, pharmacy technicians, trainees, and pharmacists who oversee vaccine and medication administration.
This Pennsylvania House resolution (HR 382) urges Congress to extend expanded health insurance subsidies that currently help Pennsylvanians purchase coverage through Pennie, the state's health insurance marketplace. Without extension, these subsidies expire December 31, 2025, causing average premium increases of 102% for Pennie customers - projected to push 150,000 people to lose coverage. The resolution highlights that without the expanded credits, a couple earning $85,000 annually would pay $25,776 yearly for insurance (31% of their income), compared to lower costs under current subsidies. It cites Pennie's 2025 enrollment of nearly 500,000 customers and a 16% drop in new sign-ups since Open Enrollment 2026 as evidence of the need for continued support. The resolution has no legal force but requests congressional action to maintain affordability.
HB 1828 requires health insurance plans in Pennsylvania to cover all recommended vaccines without requiring patients to pay out-of-pocket costs like copays or deductibles. It directly affects insurance companies by mandating this coverage and patients who rely on insurance for routine immunizations (e.g., childhood vaccines, flu shots). The bill adds penalties for insurers that fail to comply with the coverage requirement. This policy change ensures broader access to vaccines by removing financial barriers under insurance plans.
HB 1697 amends Pennsylvania's Human Services Code to create a state-level False Claims Act, directly affecting healthcare providers, contractors, and organizations receiving state funds (like Medicaid or welfare programs). It makes individuals or entities liable for three times the damages plus penalties if they knowingly submit false claims, make false records, or conceal obligations to the state. The bill establishes "qui tam" lawsuits allowing whistleblowers to sue on behalf of the state and creates a Fraud Prevention and Recovery Account to hold recovered funds. These provisions align Pennsylvania's law with the federal False Claims Act to combat fraud in public spending.
SB 95 amends Pennsylvania's Pharmacy Act to create a 180-day provisional license for pharmacists moving from other states, allowing them to practice without demonstrating competency under Pennsylvania's requirements. It also permits emergency medical services providers to distribute naloxone dose packages for opioid overdose reversal under specific conditions, including a Department of Health standing order and voluntary distribution without liability. Additionally, the bill requires pharmacies to disclose prescription drug prices (brand vs. generic), cost-sharing amounts, and health insurance options upon customer request. These changes aim to improve pharmacist mobility, expand naloxone access, and increase price transparency for consumers.
